In the present study, we show that AngII infusion, similar to TAC, caused an enhanced expression of β1 and β3 integrins and Pyk2 activation in the heart and kidney that were blunted by CSD treatment (Fig 4). The gene discussed is AGT; the disease is persistent truncus arteriosus.